They’re very simple, acute visits. cold, COVID, influenza, pink eye, urinary tract infections. We’re able to do some skin conditions if it’s a mild or minor rash,” said Nicole Goliber, physician ...

Researchers have demonstrated that inebilizumab reduced the risk of symptoms by 87 percent in patients with the rare affliction known as immunoglobulin G4-related disease (IgG4-RD).

Resubmission includes new pivotal data which confirm Dupixent significantly reduced itch and hive activityMore than 300,000 people in the U.S.

McCasland's right eye continues to be cloudy as she battles the infection. (Courtesy Brooklyn McCasland) Her medication comes ...